Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
87.00P1Mfalse--12-31Q320190000816284CELGENE CORP /DE/38000000520000000.010.01115000000011500000009815000009926000000.03550.02250.02750.028750.0...
0000816284 false 0000816284 2019-10-30 2019-10-31 0000816284 us-gaap:CommonStockMember 2019-10-30 2019-10-31 0000816284 celg:Continge...
- Strong total revenue of $4.5 billion, increased 16% Y/Y driven by volume - INREBIC® (fedratinib) granted FDA approval in myelofibrosis; EU MAA...
Wheelchair Accessible Balloon Lifts Off at Atlanta Area Festival The MS MindShift: A New View of MS initiative from Celgene Corporation (NASDAQ:...
Grants include additional geographies, areas of focus and disease targets Celgene Corporation (NASDAQ: CELG) today announced an additional ten...
Top-line analysis showed a highly statistically significant and clinically meaningful improvement in overall survival for CC-486 Celgene plans...
Data to be presented include analyses of long-term efficacy and safety of ozanimod in adults with relapsing forms of multiple sclerosis and...
0000816284 false 0000816284 2019-08-24 2019-08-25 0000816284 us-gaap:CommonStockMember 2019-08-24 2019-08-25 0000816284 celg:Continge...
Amgen To Acquire Otezla® For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future...
INREBIC provides new, once-daily oral option for patients affected by rare bone marrow cancer Celgene Corporation (NASDAQ: CELG) today announced...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
87.00P1Mfalse--12-31Q220190000816284CELGENE CORP /DE/38000000480000000.010.01115000000011500000009815000009897000000.03550.02250.02750.028750...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관